X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with GSK Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs GSK PHARMA - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA GSK PHARMA SANOFI INDIA/
GSK PHARMA
 
P/E (TTM) x 30.7 59.7 51.3% View Chart
P/BV x 5.4 11.7 46.2% View Chart
Dividend Yield % 1.7 2.1 79.2%  

Financials

 SANOFI INDIA   GSK PHARMA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
GSK PHARMA
Mar-16
SANOFI INDIA/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs4,5603,850 118.4%   
Low Rs4,4002,966 148.4%   
Sales per share (Unadj.) Rs1,028.5332.3 309.5%  
Earnings per share (Unadj.) Rs129.044.3 291.1%  
Cash flow per share (Unadj.) Rs186.047.2 393.8%  
Dividends per share (Unadj.) Rs68.0050.00 136.0%  
Dividend yield (eoy) %1.51.5 103.5%  
Book value per share (Unadj.) Rs753.6202.7 371.7%  
Shares outstanding (eoy) m23.0384.70 27.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.410.3 42.5%   
Avg P/E ratio x34.776.9 45.2%  
P/CF ratio (eoy) x24.172.2 33.4%  
Price / Book Value ratio x5.916.8 35.4%  
Dividend payout %52.7112.9 46.7%   
Avg Mkt Cap Rs m103,174288,643 35.7%   
No. of employees `0003.64.6 78.6%   
Total wages/salary Rs m3,5924,434 81.0%   
Avg. sales/employee Rs Th6,537.76,104.5 107.1%   
Avg. wages/employee Rs Th991.4961.6 103.1%   
Avg. net profit/employee Rs Th819.8813.7 100.7%   
INCOME DATA
Net Sales Rs m23,68628,148 84.1%  
Other income Rs m7081,218 58.1%   
Total revenues Rs m24,39429,366 83.1%   
Gross profit Rs m5,2814,774 110.6%  
Depreciation Rs m1,313248 529.4%   
Interest Rs m150-   
Profit before tax Rs m4,6615,744 81.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m026 0.0%   
Tax Rs m1,6912,018 83.8%   
Profit after tax Rs m2,9703,752 79.2%  
Gross profit margin %22.317.0 131.5%  
Effective tax rate %36.335.1 103.3%   
Net profit margin %12.513.3 94.1%  
BALANCE SHEET DATA
Current assets Rs m15,67321,462 73.0%   
Current liabilities Rs m6,67810,536 63.4%   
Net working cap to sales %38.038.8 97.8%  
Current ratio x2.32.0 115.2%  
Inventory Days Days7668 112.3%  
Debtors Days Days2216 135.9%  
Net fixed assets Rs m8,0984,717 171.7%   
Share capital Rs m230847 27.2%   
"Free" reserves Rs m17,08816,308 104.8%   
Net worth Rs m17,35617,171 101.1%   
Long term debt Rs m016 0.0%   
Total assets Rs m25,40030,620 83.0%  
Interest coverage x311.7NM-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.90.9 101.4%   
Return on assets %11.812.3 95.9%  
Return on equity %17.121.9 78.3%  
Return on capital %26.933.6 80.3%  
Exports to sales %24.50 172,344.9%   
Imports to sales %28.015.1 185.9%   
Exports (fob) Rs m5,8014 145,025.0%   
Imports (cif) Rs m6,6274,237 156.4%   
Fx inflow Rs m7,145519 1,376.7%   
Fx outflow Rs m6,8468,320 82.3%   
Net fx Rs m299-7,801 -3.8%   
CASH FLOW
From Operations Rs m3,2261,386 232.8%  
From Investments Rs m-1,5555,010 -31.0%  
From Financial Activity Rs m-1,818-6,383 28.5%  
Net Cashflow Rs m-14712 -1,245.8%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 60.4 50.7 119.1%  
Indian inst/Mut Fund % 14.4 10.2 141.2%  
FIIs % 14.6 23.8 61.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 15.4 68.2%  
Shareholders   15,184 102,036 14.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   ALEMBIC LTD  SUN PHARMA  PIRAMAL ENTERPRISES  FDC LTD.  AUROBINDO PHARMA  

Compare SANOFI INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Negative Note; IT Sector Down 2.4%(11:30 am)

After opening the day on a negative note, share markets in India continued to witness losses. Sectoral indices are trading on a mixed note with stocks in the IT sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Aug 18, 2017 12:33 PM

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - FULFORD INDIA COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS